About: CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
value	CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
Subject	Carbonate minerals Design of experiments Pyrimidones Skeletal disorders
part of	CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial
is hasSource of	covid:ann/target/6c9a8968f65b309f6dec718ab38b5b1f5e8ef905 covid:ann/target/b25ae54e9392a44e7cd97ff5b5c95232f5de66e9 covid:ann/target/ba0af078274f4b3500421cb7c9cfd8899e4bc1a0 covid:ann/target/532b1df3c3c6efeae3d700303a05183848698b37 covid:ann/target/2e85364443f31bf0213a4cb24212b252f12520cc covid:ann/target/61990ecd034d715a9121a39e81986b908e3eda03 covid:ann/target/400b0d5c141224f1eed511c60e980d42a9752466 covid:ann/target/b88a94e7d7dd707abf0e79b3df9c184b0b0381a9 covid:ann/target/bc9d5ede75b0698aadc32486f73ce6cfe029aa9a covid:ann/target/ab9fd4135265446b5ab48de8abfcbc365d11fac0 covid:ann/target/7977e0de21a2cdce7aa3bfc08d43ad42ef2af95f covid:ann/target/1425f72b5303d18331767ef2f1fa57e9406865a3 covid:ann/target/731ca62a83a660c901101bb6120f07ef56d6ae1d covid:ann/target/adf16f99433d12a0e3e927e22ef6f5ce4ed17bfa covid:ann/target/b65a50e503658b4f0bc8a46780746f608eae96b7 covid:ann/target/62015cb8bd1d048e3f8883185bfee58d5e78a5ed covid:ann/target/0724e835e6e9420740aa58f3af8cc214ce6de3b8 covid:ann/target/00f1dcc3087f3f7095a2c3ebfecafd1448b24711 covid:ann/target/35f0e4bf4e8cf6d07c5ce470d6f587cb9484c930 covid:ann/target/38df33c21573a66c029cf2bfa0c45d5f4eedb91b covid:ann/target/3964e0e9f77649cd6efe11ad1afe1df69b4ccb0e covid:ann/target/ba6b1b1e1e832b50217a9c4cf0b5c28291d98b59 covid:ann/target/c9f11c045472e1d6048458003ca4efd830c81c2b covid:ann/target/3cda8500905ba94f900751414a9a9aa97b5b9cb5 covid:ann/target/529bdcf2657795c9f13ab03971ea9934746ffe17 covid:ann/target/6e32a706d5204d9fcde4424ea9f27e23095d8581
is resource representing a document's title of	CApecitabine plus Radium-223 (Xofigo™) in breast cancer patients with BONe metastases (CARBON): study protocol for a phase IB/IIA randomised controlled trial

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software